Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
- PMID: 34909404
- PMCID: PMC8641041
- DOI: 10.5501/wjv.v10.i6.301
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
Abstract
Coronavirus disease 2019 (COVID-19) has caused a global pandemic unprecedented in over a century. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a predominantly respiratory infection, various degrees of liver function abnormalities have been reported. Pre-existing liver disease in patients with SARS-CoV-2 infection has not been comprehensively evaluated in most studies, but it can critically compromise survival and trigger hepatic decompensation. The collapse of the healthcare services has negatively impacted the diagnosis, monitoring, and treatment of liver diseases in non-COVID-19 patients. In this review, we aim to discuss the impact of COVID-19 on liver disease from the experimental to the clinic perspective.
Keywords: COVID 19; Liver disease; SARS-CoV-2; Transaminases.
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: No conflicts of interest.
Figures
Similar articles
-
COVID-19 and the liver: What do we know so far?World J Hepatol. 2021 May 27;13(5):522-532. doi: 10.4254/wjh.v13.i5.522. World J Hepatol. 2021. PMID: 34131467 Free PMC article. Review.
-
Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective.World J Virol. 2022 Nov 25;11(6):453-466. doi: 10.5501/wjv.v11.i6.453. World J Virol. 2022. PMID: 36483109 Free PMC article. Review.
-
Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.Medicina (Kaunas). 2022 Dec 28;59(1):62. doi: 10.3390/medicina59010062. Medicina (Kaunas). 2022. PMID: 36676691 Free PMC article. Review.
-
Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.Hepatology. 2021 Aug;74(2):1088-1100. doi: 10.1002/hep.31684. Epub 2021 Jun 18. Hepatology. 2021. PMID: 33332624 Free PMC article. Review.
-
COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.J Clin Med. 2020 May 11;9(5):1420. doi: 10.3390/jcm9051420. J Clin Med. 2020. PMID: 32403255 Free PMC article. Review.
Cited by
-
Idiopathic Scoliosis Trends One Year After COVID-19: A Retrospective Study.Cureus. 2022 Dec 21;14(12):e32779. doi: 10.7759/cureus.32779. eCollection 2022 Dec. Cureus. 2022. PMID: 36686078 Free PMC article.
-
Liver and Inflammatory Biomarkers Are Related to High Mortality in Hospitalized Patients with COVID-19 in Brazilian Amazon Region.Life (Basel). 2024 Jul 11;14(7):869. doi: 10.3390/life14070869. Life (Basel). 2024. PMID: 39063622 Free PMC article.
-
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212. Int J Mol Sci. 2024. PMID: 38396888 Free PMC article. Review.
References
-
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous